| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 76, 1115-1122, Copyright © 1993 by Endocrine Society
ARTICLES |
LC Giudice, BA Dsupin, IH Jin, TH Vu and AR Hoffman
Department of Gynecology and Obstetrics, Stanford University Medical Center, California 94305.
During the menstrual cycle, the endometrium undergoes characteristic changes in response to circulating sex steroids. Intense mitotic activity of glands and stroma occurs in the proliferative (estradiol- dominant) phase, and glandular secretion and stromal differentiation in the secretory (progesterone-dominant) phase. The insulin-like growth factors (IGF-I and IGF-II) promote cellular growth and differentiation and have been proposed to participate in these cyclic endometrial events, acting as mediators of steroid hormones. The objective of this study was to determine whether the messenger RNAs (mRNAs) encoding the IGF peptides and the type I and type II IGF receptors are differentially expressed in human endometrium during the menstrual cycle and in early pregnancy. A solution hybridization ribonuclease protection assay, using 32P-labeled riboprobes for IGF-I, IGF-II, and beta-actin (control), revealed IGF-I gene expression primarily in proliferative and early secretory endometrium and abundant IGF-II gene expression in mid-late secretory endometrium and early pregnancy decidua. Northern analysis, using IGF-I and IGF-II complementary DNA probes, revealed multiple IGF-I mRNAs [2-7.6 kilobase (kb)], expressed primarily in proliferative and early secretory endometrium, and IGF-II mRNAs (1.4-6.0 kb), expressed primarily in secretory endometrium and in early pregnancy decidua. The 7.6-kb IGF-I mRNA and the 6.0-kb IGF-II mRNA were most abundantly expressed. IGF-IEa and IGF-IEb mRNA splicing variants were present in a ratio of about 9:1, respectively. Type I and type II IGF receptor gene expression in endometrium was investigated using specific riboprobes and the ribonuclease protection assay. Messenger RNAs encoding both receptors were more abundantly expressed in the secretory phase and during early pregnancy, compared to the proliferative phase. These results show that mRNAs encoding the IGF peptides and their receptors are differentially expressed in human endometrium, depending on the steroid hormone milieu. The preferential expression of IGF-I mRNA in the proliferative phase supports the hypothesis that IGF-I is an estromedin in human endometrium. The expression of endometrial IGF-II mRNA in the mid to late secretory phase and in early pregnancy supports a role for IGF-II in differentiative functions of the endometrium, perhaps including endometrial tissue shedding in the menstrual cycle or remodeling during early pregnancy.
This article has been cited by other articles:
![]() |
M. C. Satterfield, K. Hayashi, G. Song, S. G. Black, F. W. Bazer, and T. E. Spencer Progesterone Regulates FGF10, MET, IGFBP1, and IGFBP3 in the Endometrium of the Ovine Uterus Biol Reprod, December 1, 2008; 79(6): 1226 - 1236. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Matsumoto, K. Sakai, and M. Iwashita Insulin-like growth factor binding protein-1 induces decidualization of human endometrial stromal cells via {alpha}5{beta}1 integrin Mol. Hum. Reprod., August 1, 2008; 14(8): 485 - 489. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Strowitzki, A. Germeyer, R. Popovici, and M. von Wolff The human endometrium as a fertility-determining factor Hum. Reprod. Update, September 1, 2006; 12(5): 617 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. N. Jabbour, R. W. Kelly, H. M. Fraser, and H. O. D. Critchley Endocrine Regulation of Menstruation Endocr. Rev., February 1, 2006; 27(1): 17 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W.S. Chan, K. E. Schwab, and C. E. Gargett Clonogenicity of Human Endometrial Epithelial and Stromal Cells Biol Reprod, June 1, 2004; 70(6): 1738 - 1750. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Oh, W. Wu, G. Tortolero-Luna, R. Broaddus, D. M. Gershenson, T. W. Burke, R. Schmandt, and K. H. Lu Increased Plasma Levels of Insulin-Like Growth Factor 2 and Insulin-Like Growth Factor Binding Protein 3 Are Associated with Endometrial Cancer Risk Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 748 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Gopalkrishnan, R.R. Katkam, G. Sachdeva, S.D. Kholkute, V. Padwal, and C.P. Puri Effects of an Antiprogestin Onapristone on the Endometrium of Bonnet Monkeys: Morphometric and Ultrastructural Studies Biol Reprod, June 1, 2003; 68(6): 1959 - 1967. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Kim, H. S. Taylor, G. E. Akbas, I. Foucher, A. Trembleau, R. C. Jaffe, A. T. Fazleabas, and T. G. Unterman Regulation of Insulin-Like Growth Factor Binding Protein-1 Promoter Activity by FKHR and HOXA10 in Primate Endometrial Cells Biol Reprod, January 1, 2003; 68(1): 24 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Cornet, C. Picquet, P. Lemoine, K. G. Osteen, K. L. Bruner-Tran, S. Tabibzadeh, P. J. Courtoy, Y. Eeckhout, E. Marbaix, and P. Henriet Regulation and Function of LEFTY-A/EBAF in the Human Endometrium. mRNA EXPRESSION DURING THE MENSTRUAL CYCLE, CONTROL BY PROGESTERONE, AND EFFECT ON MATRIX METALLOPROTEINASES J. Biol. Chem., November 1, 2002; 277(45): 42496 - 42504. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Gray, F. F. Bartol, B. J. Tarleton, A. A. Wiley, G. A. Johnson, F. W. Bazer, and T. E. Spencer Developmental Biology of Uterine Glands Biol Reprod, November 1, 2001; 65(5): 1311 - 1323. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Taylor, C. Chen, C. A. Gray, F. W. Bazer, and T. E. Spencer Expression of Messenger Ribonucleic Acids for Fibroblast Growth Factors 7 and 10, Hepatocyte Growth Factor, and Insulin-Like Growth Factors and Their Receptors in the Neonatal Ovine Uterus Biol Reprod, April 1, 2001; 64(4): 1236 - 1246. [Abstract] [Full Text] |
||||
![]() |
E. Pierro, F. Minici, O. Alesiani, F. Miceli, C. Proto, I. Screpanti, S. Mancuso, and A. Lanzone Stromal-Epithelial Interactions Modulate Estrogen Responsiveness in Normal Human Endometrium Biol Reprod, March 1, 2001; 64(3): 831 - 838. [Abstract] [Full Text] |
||||
![]() |
N. Desai, J. Lawson, and J. Goldfarb Assessment of growth factor effects on post-thaw development of cryopreserved mouse morulae to the blastocyst stage Hum. Reprod., February 1, 2000; 15(2): 410 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-S. Wang, T.-H. Wang, and Y.-K. Soong Elevation of insulin-like growth factor-binding protein-1 mRNA expression following hormone replacement therapy Hum. Reprod., January 1, 2000; 15(1): 50 - 54. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. O. Adesanya, J. Zhou, C. Samathanam, L. Powell-Braxton, and C. A. Bondy Insulin-like growth factor 1 is required for G2 progression in the estradiol-induced mitotic cycle PNAS, March 16, 1999; 96(6): 3287 - 3291. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rajah, R. V. Nachajon, M. H. Collins, H. Hakonarson, M. M. Grunstein, and P. Cohen Elevated Levels of the IGF-Binding Protein Protease MMP-1 in Asthmatic Airway Smooth Muscle Am. J. Respir. Cell Mol. Biol., February 1, 1999; 20(2): 199 - 208. [Abstract] [Full Text] |
||||
![]() |
Y. Zhu and J. E. Pintar Expression of Opioid Receptors and Ligands in Pregnant Mouse Uterus and Placenta Biol Reprod, October 1, 1998; 59(4): 925 - 932. [Abstract] [Full Text] |
||||
![]() |
G. Dong, R. Rajah, T. Vu, A. R. Hoffman, R. G. Rosenfeld, C. T. Roberts Jr., D. M. Peehl, and P. Cohen Decreased Expression of Wilms' Tumor Gene WT-1 and Elevated Expression of Insulin Growth Factor-II (IGF-II) and Type 1 IGF Receptor Genes in Prostatic Stromal Cells from Patients with Benign Prostatic Hyperplasia J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2198 - 2203. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Martina, E. Kim, U. Chitkara, N. C. Wathen, T. Chard, and L. C. Giudice Gestational Age-Dependent Expression of Insulin-Like Growth Factor-Binding Protein-1 (IGFBP-1) Phosphoisoforms in Human Extraembryonic Cavities, Maternal Serum, and Decidua Suggests Decidua as the Primary Source of IGFBP-1 in these Fluids during Early Pregnancy J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1894 - 1898. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rajah, B. Valentinis, and P. Cohen Insulin-like Growth Factor (IGF)-binding Protein-3 Induces Apoptosis and Mediates the Effects of Transforming Growth Factor-beta 1 on Programmed Cell Death through a p53- and IGF-independent Mechanism J. Biol. Chem., May 2, 1997; 272(18): 12181 - 12188. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |